# Continuous Glucose Monitoring in Polycystic Ovarian Syndrome

> **NCT07392476** · — · ACTIVE_NOT_RECRUITING · sponsor: **The Cleveland Clinic** · enrollment: 40 (estimated)

## Conditions studied

- Polycystic Ovarian Syndrome (PCOS)

## Interventions

- **DEVICE:** Stelo glucose biosensor by Dexcom

## Key facts

- **NCT ID:** NCT07392476
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-12-24
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-08-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07392476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07392476, "Continuous Glucose Monitoring in Polycystic Ovarian Syndrome". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07392476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*